abs266.txt	the	purpose	of	this	systematic	literature	review	was	to	identify	clinical	trialsof	mds	and	aml	that	included	patient-reported	outcome	(pro)	instruments		and	tosummarize	the	symptom	and	other	health	related	quality	of	life	(hrqol)	conceptsmost	frequently	assessed	and	the	pro	instruments	that	were	used		sixteenmanuscripts	describing	14	distinct	trials	met	all	criteria	(i	e			phase	2	or	3clinical	trial	for	mds	or	aml	which	included	pro	assessment)	and	were	publishedbetween	1996-2017		in	trials	evaluating	anemia		pro	scores	showed	significantimprovement	in	relevant	domains	(e	g		fatigue		function)	among	patientsidentified	as	responders		in	trials	evaluating	the	impact	of	anti-cancertherapies		improvements	the	baseline	to	end	of	treatment	were	observed	inphysical	functioning	and	hrqol		however	the	rates	of	missing	data	in	many	of	thetrials	was	high	or	unreported		pro	instruments	have	the	ability	to	capturechanges	over	time	in	patients'	function	and	well-being		and	pro	instruments	andguidance	documents	are	available	to	support	the	assessment	of	hrqol	in	aml/mdsclinical	trials	
